Frazier Life Sciences Management, L.P. Pep Gen Inc. Call Options Transaction History
Frazier Life Sciences Management, L.P.
- $1.9 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PEPG
# of Institutions
54Shares Held
13.5MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY1.52MShares$25.4 Million0.96% of portfolio
-
Viking Global Investors LP1.48MShares$24.7 Million0.08% of portfolio
-
Perceptive Advisors LLC New York, NY1.41MShares$23.5 Million0.44% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.33MShares$22.2 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X01.17MShares$19.5 Million0.01% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $394M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...